Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
NCT03035305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36717
Last updated 2017-01-30
Summary
SMC LNS Mali is a interventional matched-pair clustered cohort carried out between August and November 2017 in 18 health areas in Kolokani Circle, Koulikoro region, Mali.
The objective of this study is to determine whether the association SMC and LNS reduces the number of confirmed malaria cases among children 6-59 months during the monthly SMC distribution sessions.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Lipid-based Nutrient Supplement (LNS)
For each round of SMC distribution (total of 4 rounds): * For children aged 6-11 months: 15 sachets/month or 50g every two days for 4 weeks * For children aged 12-59 months: 21 sachets/month or 50g per day for 3 weeks
- DRUG
-
Seasonal malaria chemoprevention
For each round of SMC distribution (total of 4 rounds): * For children aged 6-11 months: sulfadoxine 250mg/pyrimethamine 12.5mg and amodiaquine 75mg * For children aged 12-59 months: sulfadoxine 500mg/pyrimethamine 25mg and amodiaquine 150mg D1 : 1 tablet sulfadoxine-pyrimethamine + 1 tablet amodiaquine D2 : 1 tablet amodiaquine D3 : 1 tablet amodiaquine
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
Alliance médicale contre le paludisme, Mali
collaborator UNKNOWN -
Programme national de lutte contre le paludisme, Mali
collaborator UNKNOWN -
United States Agency for International Development (USAID)
collaborator FED - collaborator OTHER
-
Ministry of health, Mali
collaborator UNKNOWN -
Alliance for International Medical Action
lead OTHER
Principal Investigators
-
Susan Shepherd, MD · The Alliance for International Medical Action (ALIMA)
-
Renaud Becquet, PhD · Inserm U1219 Bordeaux Population Health Center, University of Bordeaux
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- Mali
More Related Trials
-
Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery
NCT02646410 ·Status: UNKNOWN ·Phase: NA
-
A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children
NCT00738946 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
NCT05354258 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Seasonal Malaria Chemoprevention in Kita
NCT02894294 ·Status: COMPLETED
-
Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)
NCT05878366 ·Status: COMPLETED ·Phase: NA
-
Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in Mali
NCT00623155 ·Status: COMPLETED ·Phase: NA
-
Malaria Vaccine in Children in Mali
NCT00341250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Parasite Clearance and Protection from Infection (PCPI) in Cameroon
NCT06173206 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa
NCT03855995 ·Status: COMPLETED
-
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso
NCT00261222 ·Status: COMPLETED ·Phase: PHASE2
-
Perennial Malaria Chemoprevention (PMC) Effect Study
NCT06155448 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and Malnutrition
NCT04238845 ·Status: UNKNOWN ·Phase: NA
-
L9LS MAb in Malian Infants
NCT06461026 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention
NCT05085340 ·Status: COMPLETED
-
Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana
NCT00857077 ·Status: COMPLETED ·Phase: NA
-
Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
NCT02535767 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post-discharge Malaria Chemoprevention Implementation Trial in Benin
NCT06601712 ·Status: RECRUITING ·Phase: PHASE4
-
Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children
NCT06524336 ·Status: ACTIVE_NOT_RECRUITING
-
MDA and Targeted Control Against Plasmodium Carriage in the Sahel
NCT07281443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
NCT04301531 ·Status: COMPLETED ·Phase: NA
-
Intermittent Preventive Treatment in Infant in Mali
NCT00766662 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal
NCT00712374 ·Status: UNKNOWN ·Phase: PHASE4
-
Chemoprevention Efficacy Study Nigeria
NCT05979896 ·Status: UNKNOWN ·Phase: PHASE4
-
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine
NCT03599596 ·Status: UNKNOWN ·Phase: PHASE1
-
Age of Exposure and Immunity to Malaria in Infants
NCT00231452 ·Status: COMPLETED ·Phase: NA